Market Overview:
The global cardiac marker testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in cardiac marker testing, and rising demand for early diagnosis and treatment of heart diseases. The global cardiac marker testing market is segmented on the basis of type, application, and region. The ELISA segment is expected to grow at a CAGR of 8% from 2018 to 2030 owing to its high accuracy and sensitivity as compared with other methods. On the basis of application, the market is divided into pharmaceutical companies, reagents manufacturers & suppliers/distributors/dealers/resellers for diagnostic laboratories & hospitals), imaging instrument providers (cardiac CT scan systems; echocardiography systems; nuclear cardiology systems) and others including contract research organizations (CROs) & central laboratories).
Product Definition:
Cardiac marker testing is a blood test that measures the levels of certain proteins in the blood that are released by the heart muscle. These proteins can be used to diagnose a heart attack or to see how well your heart is working.
Chemiluminescence:
Chemiluminescence is the light generated when chemical reactions take place. Chemiluminescence detection has wide applications in clinical laboratories and research institutes for various biological fluids such as urine, blood, saliva, sweat & tears. The major factor driving the growth of this market includes increasing demand for early disease diagnosis and growing R&D activities by many biotechnology companies to develop novel diagnostic techniques which are cost-effective and easily available.
Immunofluorescence:
The global immunofluorescence and its usage in cardiac marker testing market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of cardiovascular diseases, increasing geriatric population base, growing awareness about these procedures among patients & healthcare professionals and technological advancements are some major factors that drive the growth of this market globally.
Application Insights:
The pharmaceutical companies application segment accounted for the largest share in 2017. The presence of key players such as Amgen, Inc.; Pfizer; and sanofi-aventis U.S., among others are contributing to the large share held by this segment. These companies are engaged in R&D activities for developing new diagnostic tests for various diseases that require minimal invasive procedures and produce minimal side effects compared to other methods available in the market at present times.
Cardiac biomarkers have found their utility not only as a predictive tool but also as a therapeutic target during clinical trials, which is expected to boost its demand over the forecast period from 2018 to 2030. In addition, these biomarkers act as an early indicator of cardiovascular disease (CVD) thus providing critical information regarding patient prognosis thereby boosting its demand worldwide over the forecast period from 2018 to 2030 to be followed by genetic testing using polymerase chain reaction (PCR).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate for advanced technologies, and favorable reimbursement policies & regulatory reforms in this region. Moreover, increasing demand for diagnostic products and services is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels and improving healthcare facilities coupled with an increase in government spending on health sector initiatives such as establishment of new hospitals & clinics as well as upgradation of existing medical infrastructure. These factors are expected to boost demand for cardiac markers testing products during the forecast period which will subsequently propel regional market growth over the next eight years (from 2018 to 2030).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) due to changing lifestyles and aging population
- Growing demand for early diagnosis and treatment of CVDs
- Technological advancements in cardiac marker testing that improve accuracy and speed of diagnosis
- Rising awareness about the benefits of early detection of heart problems among patients and healthcare professionals
- Expansion of private diagnostic laboratories that offer cardiac marker testing services
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Marker Testing Market Research Report
By Type
Chemiluminescence, Immunofluorescence, ELISA, Immunochromatography, Others
By Application
Pharmaceutical Companies, Reagents Manufacturers, Imaging Instrument Providers, Others
By Companies
Roche Diagnostics, Abbott Laboratories, Siemens, Danaher Corporation, Alere Inc, BioMerieux, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, Guangzhou Wondfo Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Marker Testing Market Report Segments:
The global Cardiac Marker Testing market is segmented on the basis of:
Types
Chemiluminescence, Immunofluorescence, ELISA, Immunochromatography, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Reagents Manufacturers, Imaging Instrument Providers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abbott Laboratories
- Siemens
- Danaher Corporation
- Alere Inc
- BioMerieux
- LSI Medience Corporation
- Ortho Clinical Diagnostics
- Randox Laboratories Ltd
- Guangzhou Wondfo Biotech
Highlights of The Cardiac Marker Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemiluminescence
- Immunofluorescence
- ELISA
- Immunochromatography
- Others
- By Application:
- Pharmaceutical Companies
- Reagents Manufacturers
- Imaging Instrument Providers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Marker Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac marker testing is a procedure that uses blood samples to measure the levels of certain cardiac markers. These markers can help doctors diagnose heart problems and monitor treatment.
Some of the major players in the cardiac marker testing market are Roche Diagnostics, Abbott Laboratories, Siemens, Danaher Corporation, Alere Inc, BioMerieux, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, Guangzhou Wondfo Biotech.
The cardiac marker testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Marker Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Marker Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Marker Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Marker Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Marker Testing Market Size & Forecast, 2020-2028
4.5.1 Cardiac Marker Testing Market Size and Y-o-Y Growth
4.5.2 Cardiac Marker Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chemiluminescence
5.2.2 Immunofluorescence
5.2.3 ELISA
5.2.4 Immunochromatography
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Reagents Manufacturers
6.2.3 Imaging Instrument Providers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Marker Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Marker Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chemiluminescence
9.6.2 Immunofluorescence
9.6.3 ELISA
9.6.4 Immunochromatography
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Reagents Manufacturers
9.10.3 Imaging Instrument Providers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chemiluminescence
10.6.2 Immunofluorescence
10.6.3 ELISA
10.6.4 Immunochromatography
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Reagents Manufacturers
10.10.3 Imaging Instrument Providers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chemiluminescence
11.6.2 Immunofluorescence
11.6.3 ELISA
11.6.4 Immunochromatography
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Reagents Manufacturers
11.10.3 Imaging Instrument Providers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chemiluminescence
12.6.2 Immunofluorescence
12.6.3 ELISA
12.6.4 Immunochromatography
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Reagents Manufacturers
12.10.3 Imaging Instrument Providers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chemiluminescence
13.6.2 Immunofluorescence
13.6.3 ELISA
13.6.4 Immunochromatography
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Reagents Manufacturers
13.10.3 Imaging Instrument Providers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Marker Testing Market: Competitive Dashboard
14.2 Global Cardiac Marker Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Abbott Laboratories
14.3.3 Siemens
14.3.4 Danaher Corporation
14.3.5 Alere Inc
14.3.6 BioMerieux
14.3.7 LSI Medience Corporation
14.3.8 Ortho Clinical Diagnostics
14.3.9 Randox Laboratories Ltd
14.3.10 Guangzhou Wondfo Biotech
